Withdrawal-Induced Delirium in Opioid Dependence: A Systematic Review

Area of Science:

• Neuroscience
• Clinical Medicine
• Pharmacology

Background:

• Delirium is an uncommon yet significant complication of opioid withdrawal syndrome (OWS).
• Atypical presentations like delirium in OWS are underreported and difficult to diagnose due to overlapping symptoms.
• Understanding OWS-associated delirium is crucial for effective patient management.

Purpose of the Study:

• To systematically review and characterize delirium associated with opioid withdrawal.
• To identify potential risk factors and management strategies for OWS-associated delirium.
• To underscore the need for improved diagnostic and therapeutic approaches.

Main Methods:

• Systematic review of case reports and case series on delirium precipitated by opioid withdrawal.
• Inclusion criteria focused on spontaneous, tapering, or antagonist-induced withdrawal.
• Analysis of twelve papers comprising fifteen case reports.

Main Results:

• Delirium onset occurred within hours to days of withdrawal in most patients (n=15).
• Common symptoms included fluctuating consciousness, disorientation, perceptual disturbances, and psychomotor changes.
• Identified risk factors: psychiatric comorbidity, psychotropic medication, rapid detoxification, and adulterated substances.

Conclusions:

• Heightened clinical awareness is needed to differentiate OWS-associated delirium from other neuropsychiatric states and organic causes.
• Current knowledge is limited to case reports, hindering prevalence assessment and risk factor identification.
• Future research should focus on risk factors, treatment optimization, and novel diagnostic tools like AI-driven monitoring.